|
C3ORF58 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53210777398272E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.0507154842071E-14 |
| Normal-vs-Stage2 |
8.047500E-04 |
| Normal-vs-Stage3 |
4.20189999994491E-06 |
| Normal-vs-Stage4 |
1.98690000008384E-07 |
| Stage1-vs-Stage2 |
9.615400E-01 |
| Stage1-vs-Stage3 |
8.829800E-01 |
| Stage1-vs-Stage4 |
3.049600E-01 |
| Stage2-vs-Stage3 |
8.945800E-01 |
| Stage2-vs-Stage4 |
5.415800E-01 |
| Stage3-vs-Stage4 |
5.379800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63591362678517E-12 |
| Normal-vs-AfricanAmerican |
1.820160E-04 |
| Normal-vs-Asian |
1.156370E-01 |
| Caucasian-vs-AfricanAmerican |
3.291800E-02 |
| Caucasian-vs-Asian |
7.627200E-01 |
| AfricanAmerican-vs-Asian |
6.823400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64640523436788E-11 |
| Normal-vs-Female |
4.84501327946418E-13 |
| Male-vs-Female |
2.388200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.836500E-04 |
| Normal-vs-Age(41-60Yrs) |
2.45048425995265E-12 |
| Normal-vs-Age(61-80Yrs) |
7.542300117791E-11 |
| Normal-vs-Age(81-100Yrs) |
2.841400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.380200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.396600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.602800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.666000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.379800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.027810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.09479997184781E-10 |
| Normal-vs-Grade 2 |
4.93569629611557E-11 |
| Normal-vs-Grade 3 |
2.59100518817945E-11 |
| Normal-vs-Grade 4 |
1.04339999995595E-06 |
| Grade 1-vs-Grade 2 |
6.844100E-02 |
| Grade 1-vs-Grade 3 |
1.183970E-02 |
| Grade 1-vs-Grade 4 |
1.491870E-02 |
| Grade 2-vs-Grade 3 |
1.196160E-01 |
| Grade 2-vs-Grade 4 |
1.419230E-01 |
| Grade 3-vs-Grade 4 |
8.078400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.08721928629529E-14 |
| Normal-vs-ccB subtype |
2.13820000039E-07 |
| ccA subtype-vs-ccB subtype |
2.150600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.0515039907757E-11 |
| Normal-vs-N1 |
6.221600E-04 |
| N0-vs-N1 |
5.323600E-01 |
|
|
